(株)カイノスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4556/E00977 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/12/24 | 日証協 | 284,200株 | -3.69% | 700株 | -94.78% | 252,359株 | -3.07% | 2,900株 | -69.51% |
2021/12/17 | 日証協 | 295,100株 | +2.25% | 13,400株 | +88.73% | 260,358株 | +1.72% | 9,511株 | +32.08% |
2021/12/10 | 日証協 | 288,600株 | -9.1% | 7,100株 | -88.63% | 255,947株 | -4.51% | 7,201株 | -74.19% |
2021/12/03 | 日証協 | 317,500株 | +2.75% | 62,465株 | +3370.28% | 268,047株 | +6.35% | 27,901株 | +168.28% |
2021/11/26 | 日証協 | 309,000株 | -3.32% | 1,800株 | -98.02% | 252,046株 | -1.14% | 10,400株 | +89.09% |
2021/11/19 | 日証協 | 319,600株 | -6.98% | 91,000株 | +564.23% | 254,946株 | -5.31% | 5,500株 | -54.55% |
2021/11/05 | 日証協 | 352,100株 | -4.89% | 93,600株 | +23.54% | 280,846株 | -2.36% | 3,500株 | -92.32% |
2021/10/29 | 日証協 | 370,200株 | +16.56% | 75,765株 | +689.22% | 287,646株 | +11% | 45,601株 | +623.71% |
2021/10/22 | 日証協 | 317,600株 | -4.51% | 9,600株 | -29.41% | 259,145株 | -2.59% | 6,301株 | -52.63% |
2021/10/15 | 日証協 | 332,600株 | +0.51% | 13,600株 | -92.71% | 266,043株 | +1.53% | 13,301株 | +18.74% |
2021/10/08 | 日証協 | 330,900株 | +5.18% | 186,500株 | +110.34% | 262,042株 | +3.89% | 11,202株 | -84.51% |
2021/10/01 | 日証協 | 314,600株 | +19.17% | 88,665株 | +3446.6% | 252,226株 | +10.33% | 72,328株 | +815.54% |
2021/09/24 | 日証協 | 264,000株 | -5.07% | 2,500株 | -99.01% | 228,616株 | -2.93% | 7,900株 | -61.46% |
2021/09/17 | 日証協 | 278,100株 | -1.38% | 252,200株 | +131.73% | 235,516株 | +0.04% | 20,500株 | -3.76% |
2021/09/10 | 日証協 | 282,000株 | +2.58% | 108,835株 | -23.36% | 235,416株 | +1.73% | 21,300株 | +67.72% |
2021/09/03 | 日証協 | 274,900株 | -19.97% | 142,000株 | -64.21% | 231,416株 | -15.7% | 12,700株 | -90.13% |
2021/08/27 | 日証協 | 343,500株 | +166.69% | 396,760株 | +465.19% | 274,516株 | +74.72% | 128,700株 | +107.25% |
2021/08/20 | 日証協 | 128,800株 | +5.31% | 70,200株 | +1747.37% | 157,116株 | -0.06% | 62,100株 | +970.69% |
2021/08/13 | 日証協 | 122,300株 | -0.08% | 3,800株 | -91.52% | 157,216株 | +0.7% | 5,800株 | -17.15% |
※株式分割は考慮していませんのでご注意ください。
Page Top